Amgen To Participate In The 2017 World Medical Innovation Forum ™ Focused On Cardiovascular Disease

THOUSAND OAKS, Calif., April 27, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced plans to participate in the World Medical Innovation Forum™ focused on cardiovascular disease held May 1-3, 2017, in Boston. The World Medical Innovation Forum is a global gathering of senior corporate, investor and academic leaders. The forum was established to respond to the intensifying transformation of health care and its impact on innovation. This is the third year Amgen has participated in this event as a sponsor. Four senior leaders from Amgen are scheduled to speak: Robert A. Bradway, chairman and chief executive officer, will participate in a fireside chat with Scott Sperling, co-...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news